Dutch court blocks subcutaneous Keytruda in eight European countries
A Dutch court has ordered Merck to stop manufacturing and selling its injectable formulation of Keytruda in eight European countries. The court ruled that Merck infringed one of Halozyme's patents and
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.